425 related articles for article (PubMed ID: 31587989)
21. Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting.
Donaldson IA; Alonzi R; Barratt D; Barret E; Berge V; Bott S; Bottomley D; Eggener S; Ehdaie B; Emberton M; Hindley R; Leslie T; Miners A; McCartan N; Moore CM; Pinto P; Polascik TJ; Simmons L; van der Meulen J; Villers A; Willis S; Ahmed HU
Eur Urol; 2015 Apr; 67(4):771-7. PubMed ID: 25281389
[TBL] [Abstract][Full Text] [Related]
22. Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?
Ong S; Chen K; Grummet J; Yaxley J; Scheltema MJ; Stricker P; Tay KJ; Lawrentschuk N
BJU Int; 2023 Jan; 131(1):20-31. PubMed ID: 36083229
[TBL] [Abstract][Full Text] [Related]
23. EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe.
van de Velde CJ; Aristei C; Boelens PG; Beets-Tan RG; Blomqvist L; Borras JM; van den Broek CB; Brown G; Coebergh JW; Cutsem EV; Espin E; Gore-Booth J; Glimelius B; Haustermans K; Henning G; Iversen LH; Han van Krieken J; Marijnen CA; Mroczkowski P; Nagtegaal I; Naredi P; Ortiz H; Påhlman L; Quirke P; Rödel C; Roth A; Rutten HJ; Schmoll HJ; Smith J; Tanis PJ; Taylor C; Wibe A; Gambacorta MA; Meldolesi E; Wiggers T; Cervantes A; Valentini V;
Eur J Cancer; 2013 Sep; 49(13):2784-90. PubMed ID: 23769991
[TBL] [Abstract][Full Text] [Related]
24. Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting.
Aluwini SS; Mehra N; Lolkema MP; Oprea-Lager DE; Yakar D; Stoevelaar H; van der Poel H; ; Busstra M; de Jong IJ; de Reijke T; de Vries K; Heijmink S; Jenster G; Klaver S; Kneppers J; Lavalaye J; Leyten G; Moonen L; Nagaraj J; Noordzij W; Osanto S; Oving I; Schaake E; Scheenen T; Schoots I; Sedelaar M; Somford D; van den Berkmortel F; van der Hulle T; van der Voort van Zyp J; van Leeuwen P; van Moorselaar J; van Oort I; Vogel W; Westgeest H
Eur Urol Oncol; 2020 Apr; 3(2):231-238. PubMed ID: 31401014
[TBL] [Abstract][Full Text] [Related]
25. Sentinel node biopsy for prostate cancer: report from a consensus panel meeting.
van der Poel HG; Wit EM; Acar C; van den Berg NS; van Leeuwen FWB; Valdes Olmos RA; Winter A; Wawroschek F; Liedberg F; Maclennan S; Lam T;
BJU Int; 2017 Aug; 120(2):204-211. PubMed ID: 28188689
[TBL] [Abstract][Full Text] [Related]
26. European Association of Urology Section of Urolithiasis and International Alliance of Urolithiasis Joint Consensus on Retrograde Intrarenal Surgery for the Management of Renal Stones.
Zeng G; Zhao Z; Mazzon G; Pearle M; Choong S; Skolarikos A; Denstedt J; Seitz C; Olvera Pasada D; Fiori C; Bosio A; Papatsoris A; Méndez Probst CE; Perez Fentes D; Ann Git K; Wu Q; Wiseman O; Emiliani E; Farahat Y; Ilker Gökce M; Giannakopoulos S; Goumas Kartalas I; Somani B; Knoll T; de la Rosette J; Zhong J; Vinicius Maroccolo M; Saltirov L; Chew B; Wang K; Lahme S; Giusti G; Ferretti S; Yong Cho S; Geavlete P; Cansino R; Kamphuis GM; Smith D; Matlaga BR; Ghani KD; Bernardo N; Silva AD; Ng ACF; Yang S; Gao X; Traxer O; Miernik A; Liatsikos E; Priyakant Parikh K; Duvdevani M; Celia A; Yasui T; Aquino A; Alomar M; Choonhaklai V; Erkurt B; Glass J; Sriprasad S; Osther PJ; Keeley FX; Preminger GM; Cepeda Delgado M; Beltran Suarez E; Ye Z; Sarica K
Eur Urol Focus; 2022 Sep; 8(5):1461-1468. PubMed ID: 34836838
[TBL] [Abstract][Full Text] [Related]
27. Hong Kong Urological Association-Hong Kong Society of Uro-Oncology consensus statements on the management of advanced prostate cancer-2019 Updates.
Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Kwong PW; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Ma WK
Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3():12-26. PubMed ID: 33860645
[TBL] [Abstract][Full Text] [Related]
28. Radical prostatectomy versus deferred treatment for localised prostate cancer.
Vernooij RW; Lancee M; Cleves A; Dahm P; Bangma CH; Aben KK
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD006590. PubMed ID: 32495338
[TBL] [Abstract][Full Text] [Related]
29. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Jan; 65(1):124-37. PubMed ID: 24207135
[TBL] [Abstract][Full Text] [Related]
30. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G
BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328
[TBL] [Abstract][Full Text] [Related]
31. Re: Nicolas Mottet, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2021;79:243-62: Comorbidity Measurement in Patients with Prostate Cancer.
Froehner M; Koch R; Graefen M
Eur Urol; 2021 May; 79(5):e138. PubMed ID: 33612374
[No Abstract] [Full Text] [Related]
32. Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement.
Merriel SWD; Hetherington L; Seggie A; Castle JT; Cross W; Roobol MJ; Gnanapragasam V; Moore CM;
BJU Int; 2019 Jul; 124(1):47-54. PubMed ID: 30742733
[TBL] [Abstract][Full Text] [Related]
33. Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project.
Muller BG; van den Bos W; Brausi M; Fütterer JJ; Ghai S; Pinto PA; Popeneciu IV; de Reijke TM; Robertson C; de la Rosette JJ; Scionti S; Turkbey B; Wijkstra H; Ukimura O; Polascik TJ
World J Urol; 2015 Oct; 33(10):1503-9. PubMed ID: 25559111
[TBL] [Abstract][Full Text] [Related]
34. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.
van de Velde CJ; Boelens PG; Borras JM; Coebergh JW; Cervantes A; Blomqvist L; Beets-Tan RG; van den Broek CB; Brown G; Van Cutsem E; Espin E; Haustermans K; Glimelius B; Iversen LH; van Krieken JH; Marijnen CA; Henning G; Gore-Booth J; Meldolesi E; Mroczkowski P; Nagtegaal I; Naredi P; Ortiz H; Påhlman L; Quirke P; Rödel C; Roth A; Rutten H; Schmoll HJ; Smith JJ; Tanis PJ; Taylor C; Wibe A; Wiggers T; Gambacorta MA; Aristei C; Valentini V
Eur J Cancer; 2014 Jan; 50(1):1.e1-1.e34. PubMed ID: 24183379
[TBL] [Abstract][Full Text] [Related]
35. Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.
Poon DM; Chan CK; Chan TW; Cheung FY; Kwong PW; Lee EK; Leung AK; Leung SY; Ma WK; So HS; Tam PC; Ho LY
BJU Int; 2018 May; 121(5):703-715. PubMed ID: 29211320
[TBL] [Abstract][Full Text] [Related]
36. Consensus statements on the management of clinically localized prostate cancer from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology.
Ma WK; Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Kwong PW
BJU Int; 2019 Aug; 124(2):221-241. PubMed ID: 30653801
[TBL] [Abstract][Full Text] [Related]
37. Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project.
Tay KJ; Scheltema MJ; Ahmed HU; Barret E; Coleman JA; Dominguez-Escrig J; Ghai S; Huang J; Jones JS; Klotz LH; Robertson CN; Sanchez-Salas R; Scionti S; Sivaraman A; de la Rosette J; Polascik TJ
Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):294-299. PubMed ID: 28349978
[TBL] [Abstract][Full Text] [Related]
38. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.
Gillessen S; Attard G; Beer TM; Beltran H; Bjartell A; Bossi A; Briganti A; Bristow RG; Chi KN; Clarke N; Davis ID; de Bono J; Drake CG; Duran I; Eeles R; Efstathiou E; Evans CP; Fanti S; Feng FY; Fizazi K; Frydenberg M; Gleave M; Halabi S; Heidenreich A; Heinrich D; Higano CTS; Hofman MS; Hussain M; James N; Kanesvaran R; Kantoff P; Khauli RB; Leibowitz R; Logothetis C; Maluf F; Millman R; Morgans AK; Morris MJ; Mottet N; Mrabti H; Murphy DG; Murthy V; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Parker C; Poon DMC; Pritchard CC; Reiter RE; Roach M; Rubin M; Ryan CJ; Saad F; Sade JP; Sartor O; Scher HI; Shore N; Small E; Smith M; Soule H; Sternberg CN; Steuber T; Suzuki H; Sweeney C; Sydes MR; Taplin ME; Tombal B; Türkeri L; van Oort I; Zapatero A; Omlin A
Eur Urol; 2020 Apr; 77(4):508-547. PubMed ID: 32001144
[TBL] [Abstract][Full Text] [Related]
39. Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project.
Scheltema MJ; Tay KJ; Postema AW; de Bruin DM; Feller J; Futterer JJ; George AK; Gupta RT; Kahmann F; Kastner C; Laguna MP; Natarajan S; Rais-Bahrami S; Rastinehad AR; de Reijke TM; Salomon G; Stone N; van Velthoven R; Villani R; Villers A; Walz J; Polascik TJ; de la Rosette JJMCH
World J Urol; 2017 May; 35(5):695-701. PubMed ID: 27637908
[TBL] [Abstract][Full Text] [Related]
40. Developing a Fracture Risk Clinical Assessment Protocol for Long-Term Care: A Modified Delphi Consensus Process.
McArthur C; Hillier L; Ioannidis G; Adachi JD; Giangregorio L; Hirdes J; Papaioannou A
J Am Med Dir Assoc; 2021 Aug; 22(8):1726-1734.e8. PubMed ID: 32972869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
